TY  - GEN
AU  - Lee,Sujin
AU  - Yagita,Hideo
AU  - Sayers,Thomas J
AU  - Celis,Esteban
TI  - Optimized combination therapy using bortezomib, TRAIL and TLR agonists in established breast tumors
SN  - 1432-0851
PY  - 2010///0602
KW  - Animals
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Apoptosis
KW  - drug effects
KW  - Boronic Acids
KW  - Bortezomib
KW  - Cell Line, Tumor
KW  - Drug Synergism
KW  - Female
KW  - Male
KW  - Mammary Neoplasms, Experimental
KW  - drug therapy
KW  - Mice
KW  - Mice, Inbred BALB C
KW  - Mice, Transgenic
KW  - Oligodeoxyribonucleotides
KW  - Pyrazines
KW  - Rats
KW  - Receptors, TNF-Related Apoptosis-Inducing Ligand
KW  - agonists
KW  - TNF-Related Apoptosis-Inducing Ligand
KW  - Toll-Like Receptor 9
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S
UR  - https://doi.org/10.1007/s00262-010-0834-0
ER  -